United States Celecoxib Market Report 2017

January 2018 | 96 pages | ID: U1F6AD1BDD9EN
QYResearch

Abstracts

In this report, the United States Celecoxib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Celecoxib in these regions, from 2012 to 2022 (forecast).

United States Celecoxib market competition by top manufacturers/players, with Celecoxib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Shire
• Teva
• Mylan
• Chengdu Suncadia Pharmaceuticals
• Jiangsu Chiatai Qingjiang Pharmaceutical
• Anhui Heyi Chemical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 50mg Celecoxib
• 100mg Celecoxib
• 200mg Celecoxib
• 400mg Celecoxib

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Rheumatoid Arthritis
• Osteoarthritis
• Acute Pain
• Musculoskeletal Pain
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Celecoxib Market Report 2017

1 CELECOXIB OVERVIEW

1.1 Product Overview and Scope of Celecoxib
1.2 Classification of Celecoxib by Product Category
  1.2.1 United States Celecoxib Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Celecoxib Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 50mg Celecoxib
  1.2.4 100mg Celecoxib
  1.2.5 200mg Celecoxib
  1.2.6 400mg Celecoxib
1.3 United States Celecoxib Market by Application/End Users
  1.3.1 United States Celecoxib Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Rheumatoid Arthritis
  1.3.3 Osteoarthritis
  1.3.4 Acute Pain
  1.3.5 Musculoskeletal Pain
  1.3.6 Others
1.4 United States Celecoxib Market by Region
  1.4.1 United States Celecoxib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Celecoxib Status and Prospect (2012-2022)
  1.4.3 Southwest Celecoxib Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Celecoxib Status and Prospect (2012-2022)
  1.4.5 New England Celecoxib Status and Prospect (2012-2022)
  1.4.6 The South Celecoxib Status and Prospect (2012-2022)
  1.4.7 The Midwest Celecoxib Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Celecoxib (2012-2022)
  1.5.1 United States Celecoxib Sales and Growth Rate (2012-2022)
  1.5.2 United States Celecoxib Revenue and Growth Rate (2012-2022)

2 UNITED STATES CELECOXIB MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Celecoxib Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Celecoxib Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Celecoxib Average Price by Players/Suppliers (2012-2017)
2.4 United States Celecoxib Market Competitive Situation and Trends
  2.4.1 United States Celecoxib Market Concentration Rate
  2.4.2 United States Celecoxib Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Celecoxib Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CELECOXIB SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Celecoxib Sales and Market Share by Region (2012-2017)
3.2 United States Celecoxib Revenue and Market Share by Region (2012-2017)
3.3 United States Celecoxib Price by Region (2012-2017)

4 UNITED STATES CELECOXIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Celecoxib Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Celecoxib Revenue and Market Share by Type (2012-2017)
4.3 United States Celecoxib Price by Type (2012-2017)
4.4 United States Celecoxib Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CELECOXIB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Celecoxib Sales and Market Share by Application (2012-2017)
5.2 United States Celecoxib Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CELECOXIB PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Celecoxib Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Celecoxib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Shire
  6.2.2 Celecoxib Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Shire Celecoxib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.2 Celecoxib Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Mylan
  6.4.2 Celecoxib Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Chengdu Suncadia Pharmaceuticals
  6.5.2 Celecoxib Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Chengdu Suncadia Pharmaceuticals Celecoxib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Jiangsu Chiatai Qingjiang Pharmaceutical
  6.6.2 Celecoxib Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Anhui Heyi Chemical
  6.7.2 Celecoxib Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Anhui Heyi Chemical Celecoxib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 CELECOXIB MANUFACTURING COST ANALYSIS

7.1 Celecoxib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Celecoxib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Celecoxib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Celecoxib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CELECOXIB MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Celecoxib Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Celecoxib Sales Volume Forecast by Type (2017-2022)
11.3 United States Celecoxib Sales Volume Forecast by Application (2017-2022)
11.4 United States Celecoxib Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Celecoxib
Figure United States Celecoxib Market Size (K MT) by Type (2012-2022)
Figure United States Celecoxib Sales Volume Market Share by Type (Product Category) in 2016
Figure 50mg Celecoxib Product Picture
Figure 100mg Celecoxib Product Picture
Figure 200mg Celecoxib Product Picture
Figure 400mg Celecoxib Product Picture
Figure United States Celecoxib Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Celecoxib by Application in 2016
Figure Rheumatoid Arthritis Examples
Table Key Downstream Customer in Rheumatoid Arthritis
Figure Osteoarthritis Examples
Table Key Downstream Customer in Osteoarthritis
Figure Acute Pain Examples
Table Key Downstream Customer in Acute Pain
Figure Musculoskeletal Pain Examples
Table Key Downstream Customer in Musculoskeletal Pain
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Celecoxib Market Size (Million USD) by Region (2012-2022)
Figure The West Celecoxib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Celecoxib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Celecoxib Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Celecoxib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Celecoxib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Celecoxib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Celecoxib Sales (K MT) and Growth Rate (2012-2022)
Figure United States Celecoxib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Celecoxib Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Celecoxib Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Celecoxib Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Celecoxib Sales Share by Players/Suppliers
Figure 2017 United States Celecoxib Sales Share by Players/Suppliers
Figure United States Celecoxib Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Celecoxib Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Celecoxib Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Celecoxib Revenue Share by Players/Suppliers
Figure 2017 United States Celecoxib Revenue Share by Players/Suppliers
Table United States Market Celecoxib Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Celecoxib Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Celecoxib Market Share of Top 3 Players/Suppliers
Figure United States Celecoxib Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Celecoxib Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Celecoxib Product Category
Table United States Celecoxib Sales (K MT) by Region (2012-2017)
Table United States Celecoxib Sales Share by Region (2012-2017)
Figure United States Celecoxib Sales Share by Region (2012-2017)
Figure United States Celecoxib Sales Market Share by Region in 2016
Table United States Celecoxib Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Celecoxib Revenue Share by Region (2012-2017)
Figure United States Celecoxib Revenue Market Share by Region (2012-2017)
Figure United States Celecoxib Revenue Market Share by Region in 2016
Table United States Celecoxib Price (USD/MT) by Region (2012-2017)
Table United States Celecoxib Sales (K MT) by Type (2012-2017)
Table United States Celecoxib Sales Share by Type (2012-2017)
Figure United States Celecoxib Sales Share by Type (2012-2017)
Figure United States Celecoxib Sales Market Share by Type in 2016
Table United States Celecoxib Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Celecoxib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Celecoxib by Type (2012-2017)
Figure Revenue Market Share of Celecoxib by Type in 2016
Table United States Celecoxib Price (USD/MT) by Types (2012-2017)
Figure United States Celecoxib Sales Growth Rate by Type (2012-2017)
Table United States Celecoxib Sales (K MT) by Application (2012-2017)
Table United States Celecoxib Sales Market Share by Application (2012-2017)
Figure United States Celecoxib Sales Market Share by Application (2012-2017)
Figure United States Celecoxib Sales Market Share by Application in 2016
Table United States Celecoxib Sales Growth Rate by Application (2012-2017)
Figure United States Celecoxib Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Celecoxib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Celecoxib Sales Growth Rate (2012-2017)
Figure Pfizer Celecoxib Sales Market Share in United States (2012-2017)
Figure Pfizer Celecoxib Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Celecoxib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shire Celecoxib Sales Growth Rate (2012-2017)
Figure Shire Celecoxib Sales Market Share in United States (2012-2017)
Figure Shire Celecoxib Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Celecoxib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Celecoxib Sales Growth Rate (2012-2017)
Figure Teva Celecoxib Sales Market Share in United States (2012-2017)
Figure Teva Celecoxib Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Celecoxib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Celecoxib Sales Growth Rate (2012-2017)
Figure Mylan Celecoxib Sales Market Share in United States (2012-2017)
Figure Mylan Celecoxib Revenue Market Share in United States (2012-2017)
Table Chengdu Suncadia Pharmaceuticals Basic Information List
Table Chengdu Suncadia Pharmaceuticals Celecoxib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Chengdu Suncadia Pharmaceuticals Celecoxib Sales Growth Rate (2012-2017)
Figure Chengdu Suncadia Pharmaceuticals Celecoxib Sales Market Share in United States (2012-2017)
Figure Chengdu Suncadia Pharmaceuticals Celecoxib Revenue Market Share in United States (2012-2017)
Table Jiangsu Chiatai Qingjiang Pharmaceutical Basic Information List
Table Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Sales Growth Rate (2012-2017)
Figure Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Sales Market Share in United States (2012-2017)
Figure Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Revenue Market Share in United States (2012-2017)
Table Anhui Heyi Chemical Basic Information List
Table Anhui Heyi Chemical Celecoxib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Anhui Heyi Chemical Celecoxib Sales Growth Rate (2012-2017)
Figure Anhui Heyi Chemical Celecoxib Sales Market Share in United States (2012-2017)
Figure Anhui Heyi Chemical Celecoxib Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Celecoxib
Figure Manufacturing Process Analysis of Celecoxib
Figure Celecoxib Industrial Chain Analysis
Table Raw Materials Sources of Celecoxib Major Players/Suppliers in 2016
Table Major Buyers of Celecoxib
Table Distributors/Traders List
Figure United States Celecoxib Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Celecoxib Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Celecoxib Price (USD/MT) Trend Forecast (2017-2022)
Table United States Celecoxib Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Celecoxib Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Celecoxib Sales Volume (K MT) Forecast by Type in 2022
Table United States Celecoxib Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Celecoxib Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Celecoxib Sales Volume (K MT) Forecast by Application in 2022
Table United States Celecoxib Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Celecoxib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Celecoxib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Celecoxib Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources